•The revised CLARITY Act directs U.S. regulators to determine if DeFi protocols controlled by specific groups must comply with securities, commodities, and AML requirements.
•A procedural Senate vote on the measure is scheduled for Sept. 15, requiring 60 votes to advance.
•Coinbase CEO Brian Armstrong expressed support for what he views as an imminent regulatory breakthrough for the crypto industry.
•NRx Pharmaceuticals announced its subsidiary HOPE Therapeutics has begun training and deployment of Zeta Surgical's FDA-cleared Zeta TMS Robotic System.
